EE+ POEM Archive
Finerenone reduces composite cardiovascular outcome and risk of decreased eGFR, but increases risk of hyperkalemia
Finerenone reduces composite cardiovascular outcome and risk of decreased eGFR, but increases risk of hyperkalemia is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Finerenone Reduces Composite Cardiovascular Outcome and Risk of Decreased eGFR, but Increases Risk of Hyperkalemia." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315329/all/Finerenone_reduces_composite_cardiovascular_outcome_and_risk_of_decreased_eGFR__but_increases_risk_of_hyperkalemia.
Finerenone reduces composite cardiovascular outcome and risk of decreased eGFR, but increases risk of hyperkalemia. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315329/all/Finerenone_reduces_composite_cardiovascular_outcome_and_risk_of_decreased_eGFR__but_increases_risk_of_hyperkalemia. Accessed March 27, 2023.
Finerenone reduces composite cardiovascular outcome and risk of decreased eGFR, but increases risk of hyperkalemia. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315329/all/Finerenone_reduces_composite_cardiovascular_outcome_and_risk_of_decreased_eGFR__but_increases_risk_of_hyperkalemia
Finerenone Reduces Composite Cardiovascular Outcome and Risk of Decreased eGFR, but Increases Risk of Hyperkalemia [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2023 March 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315329/all/Finerenone_reduces_composite_cardiovascular_outcome_and_risk_of_decreased_eGFR__but_increases_risk_of_hyperkalemia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Finerenone reduces composite cardiovascular outcome and risk of decreased eGFR, but increases risk of hyperkalemia
ID - 1315329
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315329/all/Finerenone_reduces_composite_cardiovascular_outcome_and_risk_of_decreased_eGFR__but_increases_risk_of_hyperkalemia
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
